节点文献

增强型自杀基因载体治疗宫颈癌的体外实验研究

In vitro research of enhanced suicide gene vector for cervix cancer therapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王丽娜张雅坤周银李剑尹彪李琼潘乾薛志刚夏昆梁德生夏家辉

【Author】 WANG Li-Na,ZHANG Ya-Kun,ZHOU Yin,LI Jian,YIN Biao,LI Qiong, PAN Qian,XUE Zhi-Gang,XIA Kun,LIANG De-sheng,XIA Jia-hui(National Lab of Medical Genetics of China,Central South University, Changsha,Hunan 410078 P.R.China)

【机构】 中南大学中国医学遗传学国家重点实验室中南大学中国医学遗传学国家重点实验室 湖南长沙410078湖南长沙410078

【摘要】 目的探讨运用增强子增强hTERT启动子转录活性后,调控双自杀融合基因CDTK载体对人宫颈癌HeLa细胞的体外杀伤作用。方法将SV40增强子、CMV增强子、CMV增强子/启动子及SV40-CMV双增强子分别与hTERT启动子组合构建成报告基因载体,转染HeLa细胞后用双荧光素酶系统分析其活性差异;然后构建pHr-SCT/CDTKG治疗载体转染HeLa细胞,用流式细胞仪检测转染效率,RT-PCR检测融合自杀基因mRNA表达,HPLC检测5-FU浓度,MTT分析载体杀瘤的效果。结果HeLa细胞中增强子能使hTERT启动子活性提高6~13倍,其中SV40-CMV双增强子/hTERT启动子的活性最高,达到CMV增强子/启动子的近3倍;体外转染pHr-SCT/CDTKG后可检测到CDTK的mRNA的表达;细胞上清中5-FU最高浓度为50.83ug/mL;当5-FC浓度为200ug/mL、GCV浓度为10ug/mL时,HeLa细胞的相对细胞存活率为48.7%。结论SV40-CMV双增强子联合hTERT启动子能高效靶向的调控CDTK融合自杀基因杀伤宫颈癌细胞,因而是一种很有前景的基因治疗宫颈癌的策略。

【Abstract】 [Objective] To investigate the in vitro effects of CDTK/5-FC+GCV on cervix cancer cell line,HeLa cells with an enhanced human hTERT promoter vector system.[Methods] Six transcriptional regulatory elements were constructed by appending a CMV or SV40 enhancer or CMV enhancer/promoter 5’ to the hTERT promoter and further appending a SV40 enhancer to the CMV enhancer/hTERT promoter.Enhanced hTERT promoter activity was determined by luciferase assay after these plasmids were transfected into HeLa cells.Eukaryotic expression vector,pHr-SCT/CDTKG containing a CDTK fusion suicide gene under the control of hTERT promoter combined with the SV40-CMV double enhancers was constructed and transfected into HeLa cells by electroporation.Transfection efficiency was counted by flow cytometry.The mRNA expression of CDTK gene was detected by RT-PCR.Following the transfection,5-FC and GCV were added and high performance liquid chromatography(HPLC) method was applied to determine the level of 5-FU in the supernatant of the transfected cells.Methyl thiazolyl tetrazolium(MTT) assay was used to investigate the anti-tumor effects of pHr-SCT/CDTKG/5-FC+GCV on HeLa cells.[Results] The augmentations of the hTERT promoter activity by those enhancers were increased from 6 to 13 times.Among them the SV40-CMV double enhancers/hTERT promoter reached the highest level and their transcription activity was as nearly 3 times as the CMV enhancer/promoter which was popular used.Also,the CDTK fusion suicide gene was successfully transcribed confirmed by RT-PCR after the transfection.The highest concentration of 5-FU in supernatant of the cells was 92.73 ug/ml.And the relative cell survival rate achieved 48.7% when 5-FC was at 200 ug/mL and GCV was at 10 ug/mL.[Conclusion] The targeting and efficient expression of the fusion suicide gene CDTK regulated by the SV40-CMV double enhancers/hTERT promoter could effectively kill Hela cells in vitro,which can be a promising strategy of gene therapy for cervix cancer.

  • 【文献出处】 中国医学工程 ,China Medical Engineering , 编辑部邮箱 ,2006年06期
  • 【分类号】R737.33
  • 【被引频次】16
  • 【下载频次】92
节点文献中: 

本文链接的文献网络图示:

本文的引文网络